Yazar "Hizal, Mutlu" için Fakülteler listeleme
-
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study
Hizal, Mutlu; Bilgin, Burak; Paksoy, Nail; Acıkgöz, Özgür; Sezer, Ahmet; Gürbüz, Mustafa; Sendur, Mehmet Ali Nahit; İriağaç, Yakup (Springer, 2021)Introduction Osimertinib, an irreversible third-generation EGFR-TKI, is the standard of care for second-line treatment of T790M-mutant advanced NSCLC patients whose disease progressed after first-line EGFR-TKI therapy. In ...